Latest filing published 04 Mar 2026 for Aurinia Pharmaceuticals Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Joseph Miller: trading record in brief
All filings by Joseph Miller on record concern Aurinia Pharmaceuticals Inc. Over a trading history stretching from 27 April 2020 to 2 March 2026, the count stands at 15 filings.
Purchases make up the whole of the open-market record (1 purchase, €6,629). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 4 share grants and 9 option exercises.
The record was last updated on 4 March 2026 with an option exercise in Aurinia Pharmaceuticals Inc. The most recent open-market purchase was published on 11 May 2021, 2,008 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joseph Miller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 38,963 sharesCommon SharesTSXSEDI:4670967
- 32,960 sharesCommon SharesTSXSEDI:4663940
- 2,889 sharesCommon SharesTSXSEDI:4635077
- 12,492 sharesCommon SharesTSXSEDI:4635076
- 29,223 sharesCommon SharesTSXSEDI:4635075
- 32,431 sharesCommon SharesTSXSEDI:4465120
- 3,278 sharesCommon SharesTSXSEDI:4465106
- 17,169 sharesCommon SharesTSXSEDI:4465130
- 28,448 sharesCommon SharesTSXSEDI:4465126
- 37,845 sharesCommon SharesTSXSEDI:4465135
- 3,474 sharesCommon SharesTSXSEDI:4262523
- 23,397 sharesCommon SharesTSXSEDI:4089967
- 2,399 sharesCommon SharesTSXSEDI:4089970
- 1,000 shares@ CA$9.74100.0% of flowCommon SharesTSXSEDI:3741917Canonical exit: 9 Aug 2021 (T+90)
- Common SharesTSXSEDI:3544233
15 of 15 declarations
